CVE-2019-13535 — In Medtronic Valleylab FT10 Energy Platform (VLFT10GEN) version 2

In Medtronic Valleylab FT10 Energy Platform (VLFT10GEN) version 2.1.0 and lower and version 2.0.3 and lower, and Valleylab LS10 Energy Platform (VLLS10GEN—not available in the United States) version 1.20.2 and lower, the RFID security mechanism does not apply read protection, all

01What is this vulnerability?

In Medtronic Valleylab FT10 Energy Platform (VLFT10GEN) version 2.1.0 and lower and version 2.0.3 and lower, and Valleylab LS10 Energy Platform (VLLS10GEN—not available in the United States) version 1.20.2 and lower, the RFID security mechanism does not apply read protection, allowing for full read access of the RFID security mechanism data.

02Affected products

Vendor	Product	Versions
Medtronic	Valleylab FT10 Energy Platform (VLFT10GEN)	0, 0
Medtronic	Valleylab LS10 Energy Platform (VLLS10GEN	not available in the United States) — 0

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2019-11-08T19:45:55.000Z
• Last modified: 2025-05-22T18:39:28.797Z

09References

• global.medtronic.com — https://global.medtronic.com/xg-en/product-security/security-bulletins/valleylab…
• www.cisa.gov — https://www.cisa.gov/news-events/ics-medical-advisories/icsma-19-311-01